Orna Therapeutics acquires ReNAgade Therapeutics, appoints new CEO to lead RNA therapeutics innovation
Orna Therapeutics, a pioneer in the field of circular RNA therapeutics, has officially announced its acquisition of ReNAgade Therapeutics, a company renowned for its significant ... Read More
Thermo Fisher Scientific achieves GMP approval in Italy for RNA-based products
In a significant advancement for the pharmaceutical and biotechnology industry, Thermo Fisher Scientific, a global leader in scientific services, has received Good Manufacturing Practice (GMP) ... Read More
Twentyeight-Seven Therapeutics launches with $65m to develop RNA-modulating cancer therapies
In an ambitious move within the biotechnology sector, a new U.S. biotech company, Twentyeight-Seven Therapeutics (28-7), has been established in Cambridge with a primary focus ... Read More